Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 20, 2025 • 11:11 AM ET

Date/Time Source News Release
01/07/2025 07:30 AM EST GlobeNewswire Final Study Completed for Cingulate's Lead Asset CTx-1301
12/23/2024 07:30 AM EST GlobeNewswire Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000
11/07/2024 07:30 AM EST GlobeNewswire Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
10/08/2024 03:15 PM EDT GlobeNewswire Cingulate's Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
09/12/2024 08:30 AM EDT GlobeNewswire Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
08/27/2024 04:30 PM EDT GlobeNewswire Cingulate to Participate in Benzinga All Live Access Event
08/23/2024 04:45 PM EDT GlobeNewswire Cingulate Announces Adjournment of Special Meeting
08/15/2024 07:45 AM EDT GlobeNewswire Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD
08/13/2024 07:45 AM EDT GlobeNewswire Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones Achieved
06/28/2024 09:15 AM EDT GlobeNewswire Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds
Page

Additional News

As of January 20, 2025 • 11:11 AM ET

Date/Time Source News Release
11/09/2024 04:40 AM EST US Earnings Reports Expected earnings - Cingulate Inc.
11/07/2024 01:46 PM EST SeekingAlpha Cingulate reports Q3 results
09/27/2024 12:16 PM EDT SeekingAlpha Cingulate files to sell 1.5M shares of common stock for holders
09/26/2024 06:22 PM EDT Stock Traders Daily (CING) Proactive Strategies
08/20/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Tue, Aug 20, 2024 as of 10.00 am ET
08/19/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Mon, Aug 19, 2024 as of 10.00 am ET
08/16/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Fri, Aug 16, 2024 as of 4:00 pm ET
08/16/2024 02:20 PM EDT Invezz Cingulate stock surges 115% after European patent approval for ADHD treatment: Is it a buy?
08/16/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Fri, Aug 16, 2024 as of 10.00 am ET
08/15/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Thu, Aug 15, 2024 as of 4:00 pm ET
Page